The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mustafaev D.M.

LOR-klinika Moskovskogo oblastnogo nauchno-issledovatel'skogo klinicheskogo instituta im. M.F. Vladimirskogo, Moskva

IgG4-related sclerosing disease of the larynx

Authors:

Mustafaev D.M.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2017;82(2): 77‑79

Read: 1316 times


To cite this article:

Mustafaev DM. IgG4-related sclerosing disease of the larynx. Russian Bulletin of Otorhinolaryngology. 2017;82(2):77‑79. (In Russ.)
https://doi.org/10.17116/otorino201782277-79

Recommended articles:
Lary­ngeal granulomas (literature review). Russian Bulletin of Otorhinolaryngology. 2025;(5):86-93

References:

  1. Kazantseva IA, Lishchuk SV. IgG4-related sclerosing disease. Arkhiv patologii. 2011;73(3):40-43. (In Russ.).
  2. Lysenko GI, Khimion LV, Garmish EA, Danilyuk SV, Yashchenko OB. IgG4-associated diseases. Ukrainskiy revmatologicheskiy zhurnal. 2013;4:22-26. (In Russ.).
  3. Deshpande V, Zen Y. Chan JK, Yi EE, Sato Y, Yoshino T. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-1192.
  4. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41(7):626-631.
  5. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvemnt in IgG4-related systemic disease. Arthritis Rheum. 2010;62(6):1755-1762.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.